Group One Trading’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,700
| Closed | -$20.8K | – | 8407 |
|
|
2023
Q1 | $20.8K | Sell |
27,700
-15,700
| -36% | -$11.5K | ﹤0.01% | 5482 |
|
|
2022
Q4 | $16K | Buy |
43,400
+29,300
| +208% | +$12.4K | ﹤0.01% | 5743 |
|
|
2022
Q3 | $6K | Buy |
+14,100
| New | +$13.9K | ﹤0.01% | 6798 |
|
|
2022
Q2 | – | Sell |
-3,900
| Closed | -$5K | – | 8782 |
|
|
2022
Q1 | $5K | Sell |
3,900
-2,600
| -40% | -$2.39K | ﹤0.01% | 7496 |
|
|
2021
Q4 | $8K | Buy |
6,500
+5,400
| +491% | +$9.65K | ﹤0.01% | 7488 |
|
|
2021
Q3 | $2K | Sell |
1,100
-4,800
| -81% | -$13.1K | ﹤0.01% | 7983 |
|
|
2021
Q2 | $22K | Sell |
5,900
-800
| -12% | -$2.78K | ﹤0.01% | 7141 |
|
|
2021
Q1 | $22K | Buy |
6,700
+6,400
| +2,133% | +$22.9K | ﹤0.01% | 6732 |
|
|
2020
Q4 | $1K | Sell |
300
-300
| -50% | -$1.24K | ﹤0.01% | 6376 |
|
|
2020
Q3 | $2K | Sell |
600
-11,000
| -95% | -$41.8K | ﹤0.01% | 5862 |
|
|
2020
Q2 | $39K | Sell |
11,600
-11,100
| -49% | -$32.3K | ﹤0.01% | 4514 |
|
|
2020
Q1 | $53K | Sell |
22,700
-219,200
| -91% | -$600K | ﹤0.01% | 3679 |
|
|
2019
Q4 | $881K | Buy |
241,900
+241,400
| +48,280% | +$1.95M | 0.01% | 1983 |
|
|
2019
Q3 | $4K | Sell |
500
-5,500
| -92% | -$44.5K | ﹤0.01% | 4833 |
|
|
2019
Q2 | $52K | Buy |
6,000
+5,900
| +5,900% | +$52.8K | ﹤0.01% | 3755 |
|
|
2019
Q1 | $1K | Sell |
100
-4,000
| -98% | -$42.8K | ﹤0.01% | 4684 |
|
|
2018
Q4 | $36K | Sell |
4,100
-165,300
| -98% | -$2.11M | ﹤0.01% | 3729 |
|
|
2018
Q3 | $2.85M | Buy |
169,400
+38,600
| +30% | +$835K | 0.02% | 913 |
|
|
2018
Q2 | $2.74M | Buy |
130,800
+100,800
| +336% | +$1.87M | 0.02% | 900 |
|
|
2018
Q1 | $483K | Sell |
30,000
-36,400
| -55% | -$721K | ﹤0.01% | 2097 |
|
|
2017
Q4 | $1.26M | Buy |
66,400
+63,300
| +2,042% | +$1.15M | 0.01% | 1537 |
|
|
2017
Q3 | $44K | Buy |
+3,100
| New | +$28K | ﹤0.01% | 3708 |
|
|
2017
Q2 | – | Sell |
-3,000
| Closed | -$20K | – | 5213 |
|
|
2017
Q1 | $20K | Sell |
3,000
-6,200
| -67% | -$34.7K | ﹤0.01% | 3880 |
|
|
2016
Q4 | $41K | Buy |
+9,200
| New | +$38.6K | ﹤0.01% | 3367 |
|
|
2016
Q3 | – | Sell |
-2,600
| Closed | -$17K | – | 5014 |
|
|
2016
Q2 | $17K | Buy |
2,600
+2,400
| +1,200% | +$17K | ﹤0.01% | 3875 |
|
|
2016
Q1 | $1K | Buy |
+200
| New | +$1.03K | ﹤0.01% | 4464 |
|
|
2015
Q4 | – | Sell |
-15,900
| Closed | -$95K | – | 5204 |
|
|
2015
Q3 | $95K | Sell |
15,900
-41,500
| -72% | -$288K | ﹤0.01% | 3075 |
|
|
2015
Q2 | $393K | Sell |
57,400
-209,000
| -78% | -$1.33M | 0.01% | 1989 |
|
|
2015
Q1 | $1.62M | Buy |
266,400
+219,400
| +467% | +$1.46M | 0.03% | 762 |
|
|
2014
Q4 | $326K | Sell |
47,000
-2,100
| -4% | -$15.4K | ﹤0.01% | 1885 |
|
|
2014
Q3 | $400K | Buy |
49,100
+31,100
| +173% | +$243K | 0.01% | 1790 |
|
|
2014
Q2 | $146K | Sell |
18,000
-15,200
| -46% | -$115K | ﹤0.01% | 2658 |
|
|
2014
Q1 | $260K | Buy |
33,200
+1,000
| +3% | +$8.46K | ﹤0.01% | 2218 |
|
|
2013
Q4 | $285K | Buy |
32,200
+2,600
| +9% | +$23.2K | ﹤0.01% | 2123 |
|
|
2013
Q3 | $248K | Sell |
29,600
-57,400
| -66% | -$465K | ﹤0.01% | 2195 |
|
|
2013
Q2 | $649K | Buy |
+87,000
| New | +$667K | 0.02% | 1138 |
|
Group One Trading's SPPI Position: Q3 2023 in Review
Group One Trading sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 68,632 shares — an estimated $65.9K sold.
Group One Trading first reported a position in SPPI in Q2 2013 and held it in 33 quarters. The position peaked at $590K in Q4 2019. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Group One Trading reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Group One Trading sold 68,632 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $65.9K.
- Group One Trading first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
- Group One Trading's Spectrum Pharmaceuticals Inc position peaked at $590K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.